Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1377843

registered interest
date	12/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to progress the delivery of HPV vaccination, following the Minister's response to HC Deb, 25 March 2021, who stated that missed school aged vaccinations would be delivered no later than August 2021.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	73854
answer	answer is ministerial correction date of answer 17/11/2021 answer text <p>The closure of schools from 23 March 2020 interrupted the delivery of school-aged immunisation programmes, including human papillomavirus (HPV). NHS England and its commissioned school aged providers continue to implement the advice from the Joint Committee on Vaccination and Immunisation regarding HPV vaccinations. The National Health Service is therefore prioritising the first dose of HPV vaccine for all those eligible whilst working to recover those school aged immunisations which have been previously missed. The Department and NHS England are working closely with the Department for Education to ensure that schools facilitate the continuation of vaccinations and improving uptake rates for school-aged vaccinations.</p><p>Providers are currently focussed on delivering the flu vaccine in schools, as is usual for this time of year, as well as the COVID-19 and expanded flu immunisation programme. School providers will recommence work on routine and outstanding vaccinations in the new year.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 17/11/2021 17:24:07 answering member 4492 label Biography information for Maria Caulfield
tabling member	4370 label Biography information for Jess Phillips

1255023

registered interest
date	24/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to commit to achieving 90 per cent HPV vaccination coverage by 2030 as set out in the World Health Organisation’s Global Strategy to Accelerate the Elimination of Cervical Cancer.
tabling member constituency	Central Ayrshire
tabling member printed	Dr Philippa Whitford
uin	120073
answer	answer is ministerial correction date of answer 10/12/2020 answer text <p>NHS England and NHS Improvement are working closely with Public Health England and the Department to drive improvements in immunisation uptake and coverage in all routine childhood immunisations. The Department intends to publish a vaccination strategy in the near future to maintain and develop the United Kingdom’s immunisation programme.</p><p> </p><p>The human papillomavirus (HPV) vaccination is routinely administered in schools, with a target of 90% coverage for 13 to 14 year old females. Where full HPV coverage has not been attained in schools, HPV vaccination can be administered in general practice up to the age of 25 to support high levels of population coverage. A review of vaccination and immunisations in 2019 has led to reformed general practice contractual arrangements to support the delivery of vaccination activity to increase coverage. In addition, all practices are required to have a named vaccination lead, to support maximisation of uptake.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 10/12/2020 16:42:01 answering member 4380 label Biography information for Jo Churchill previous answer version 65346 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
tabling member	4385 label Biography information for Dr Philippa Whitford

1109798

registered interest
date	04/04/2019
answering body	Department for International Development
answering dept id	20
answering dept short name	International Development
answering dept sort name	International Development
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for International Development, what steps his Department is taking to encourage the vaccination of women against the HPV virus in countries in which that vaccination is not yet available or accepted.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	240947
answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>The UK is supporting the increased use of the HPV vaccine through Gavi, the Vaccine Alliance. The UK is the largest donor to Gavi, which has helped 30 countries take the first steps to introducing the HPV vaccine with the aim of vaccinating 40 million girls by 2020. This will protect the poorest and most vulnerable girls from the leading cause of cervical cancer.</p><p>UK support for Gavi is also helping accelerate the introduction of the HPV vaccine to more countries through Gavi’s market shaping and price reduction strategy, which is making the vaccine more available and affordable.</p><p>Civil society and young girls play a key role in ensuring the vaccine is accepted and in high demand. Gavi supports these groups through positive communications and messaging about the full benefits of the HPV vaccine and the protection it offers.</p><p>The UK will host Gavi’s next pledging conference in 2020, demonstrating our continued strong commitment to supporting Gavi's efforts to increase vaccinations against the HPV virus as well as other vaccine preventable diseases.</p> answering member constituency West Worcestershire answering member printed Harriett Baldwin question first answered 09/04/2019 09:45:52 answering member 4107 label Biography information for Dame Harriett Baldwin
tabling member	308 label Biography information for Mr Jim Cunningham

1022927

registered interest
date	10/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the number is of gay and bisexual men who participated in the pilot HPV vaccination programme available in sexual health clinics who were aged (a) under 25, (b) 25 to 35, (c) 35 to 45, (d) 45 to 55 and (e) 55 and over.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	200604
answer	answer is ministerial correction date of answer 18/12/2018 answer text <p>An evaluation of the first year (2016/17) of the pilot has been carried out. The following table shows the number of eligible men who have sex with men (MSM), up to age 45, who participated in the pilot human papillomavirus (HPV) vaccination programme available in sexual health clinics.</p><p> </p><p>MSM over the age of 45 years were not eligible for the HPV MSM vaccination pilot.</p><p> </p><p>The number of eligible MSM, up to age 45, participating in the HPV vaccination trial</p><table><tbody><tr><td><p> </p></td><td><p>Under 25 years</p></td><td><p>26-30 years</p></td><td><p>31-35 years</p></td><td><p>36-40 years</p></td><td><p>41-45 years</p></td></tr><tr><td><p>Vaccinated with first dose</p></td><td><p>2,323</p></td><td><p>1,965</p></td><td><p>1,748</p></td><td><p>1,399</p></td><td><p>1,145</p></td></tr></tbody></table><p> </p><p>Source: Human papillomavirus vaccination for Men who have sex with Men, 2016/17 pilot evaluation <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/678987/HPV_msm_year1_evaluation_report.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/678987/HPV_msm_year1_evaluation_report.pdf</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/12/2018 17:14:31 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson

1022929

registered interest
date	10/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when the HPV vaccination is planned to be available in sexual health clinics across England for men who have sex with men; and in how many sexual health clinics that vaccination is planned to be available in.
tabling member constituency	Washington and Sunderland West
tabling member printed	Mrs Sharon Hodgson
uin	200606
answer	answer is ministerial correction date of answer 18/12/2018 answer text <p>The phased roll out of the national human papillomavirus vaccination programme for men who have sex with men began on 1 April 2018. It is anticipated this will be completed in all sexual health and HIV clinics across England by April 2019.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/12/2018 17:16:38 answering member 4067 label Biography information for Steve Brine
tabling member	1521 label Biography information for Mrs Sharon Hodgson

780519

registered interest
date	30/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many Yellow Cards submitted to the Medicines and Healthcare Products Regulatory Agency for the HPV vaccination were classified as serious; and how many of those cases were reviewed to establish whether the patient had returned to full health in each of the last 12 months.
tabling member constituency	Mansfield
tabling member printed	Ben Bradley
uin	110360
answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) encourages anyone to report a suspected adverse reaction (ADR) to a vaccine or medicine through the Yellow Card Scheme:</p><p> </p><p><a href="http://www.mhra.gov.uk/yellowcard" target="_blank">www.mhra.gov.uk/yellowcard</a></p><p>A Yellow Card report is not proof of a side effect occurring, but a suspicion by the reporter that the vaccine or medicine may have been the cause. Such reports are kept under continual review to identify potential new risks.</p><p> </p><p>Between 31 October 2014 – 30 October 2017 a total of 649 serious suspected adverse reaction (ADR) reports with human papilloma virus (HPV) vaccines have been reported to the Medicines and Healthcare products Regulatory Agency (MHRA) via the Yellow Card Scheme (data run date: 1 November 2017). In this three year period, at least 1 million doses of HPV vaccine were administered in the United Kingdom.</p><p> </p><p>A breakdown of UK serious suspected spontaneous ADR reports received via the Yellow Card Scheme beween 31 October 2014 – 30 October 2016 by brand and year received is shown in the following table.</p><p> </p><table><tbody><tr><td><p>HPV Vaccine</p></td><td><p>Number of serious reports</p></td></tr><tr><td><p>HPV brand unspecified</p></td><td><p>181</p></td></tr><tr><td><p>Cervarix</p></td><td><p>64</p></td></tr><tr><td><p>Gardasil</p></td><td><p>390</p></td></tr><tr><td><p>Gardasil 9</p></td><td><p>18</p></td></tr><tr><td><p>Total</p></td><td><p>649</p></td></tr></tbody></table><p> </p><p>Source: MHRA sentinel database for adverse reactions</p><p> </p><p>Notes:</p><p> </p><p>The total number of reports received by vaccine brand is not equal to the totals in the table above as some reports included more than one HPV vaccine brand.</p><p> </p><p>The MHRA has received a total of 3,159 serious suspected adverse reaction reports associated with HPV vaccine (data run date 1 November 2017).</p><p> </p><p>All serious reports received via the Yellow Card Scheme are reviewed based on the details received from the reporter. Follow up letters may be sent for missing information such as vaccine brand name, batch number, medical history, results of investigations, diagnoses and details of outcome.</p><p> </p><p>The Commission on Human Medicines has thoroughly reviewed the safety of HPV vaccines and concluded that the evidence does not support a link between HPV vaccination and the development of chronic illnesses.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110248 question first answered 07/11/2017 11:31:40 answering member 4067 label Biography information for Steve Brine
tabling member	4663 label Biography information for Ben Bradley

642297

registered interest
date	22/11/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when the Joint Committee on Vaccination and Immunisation is expected to make a recommendation on the issuing of HPV vaccination for adolescent boys.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	54217
answer	answer is ministerial correction date of answer 30/11/2016 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI), advises Ministers on immunisation related issues, is currently in the process of considering the impact and cost-effectiveness of extending the human papillomavirus (HPV) vaccination to adolescent boys.</p><p> </p><p>The JCVI will need to consider mathematical modelling by Public Health England (PHE) on the impact and cost effectiveness of extending the HPV vaccination to adolescent boys, ahead of developing its advice. PHE is expected to report its modelling assessment to the Committee in early 2017.</p><p> </p><p>The JCVI will consider the analysis from PHE at the earliest opportunity. Once the Committee is satisfied it has reviewed all the necessary evidence it will then be expected to make its advice.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 30/11/2016 17:59:22 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3930 label Biography information for Caroline Lucas

642302

registered interest
date	22/11/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans he has to conduct an equality impact assessment of HPV vaccination for boys; and whether any such assessment will take place before or after a recommendation from the Joint Committee on Vaccination and Immunisation.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	54216
answer	answer is ministerial correction date of answer 30/11/2016 answer text <p>The Secretary of State for Health is under the public sector equality duty (PSED) including in relation to policies such as new vaccination programmes. Complying with the PSED requires that there is consideration of equality issues during the decision making process and implementation. The consideration of such equality issues will take place as part of the policy making process concerning human papillomavirus (HPV) vaccination for boys.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood grouped question UIN 54209 question first answered 30/11/2016 17:59:08 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3930 label Biography information for Caroline Lucas

642305

registered interest
date	22/11/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether he has requested legal advice on whether HPV vaccination for boys is required under the terms of equality legislation; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	54209
answer	answer is ministerial correction date of answer 30/11/2016 answer text <p>The Secretary of State for Health is under the public sector equality duty (PSED) including in relation to policies such as new vaccination programmes. Complying with the PSED requires that there is consideration of equality issues during the decision making process and implementation. The consideration of such equality issues will take place as part of the policy making process concerning human papillomavirus (HPV) vaccination for boys.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood grouped question UIN 54216 question first answered 30/11/2016 17:59:09 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3930 label Biography information for Caroline Lucas

522153

registered interest
date	26/05/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he made of the utility of data from the clinic in Brent and Harrow which has been providing men who have sex with men with HPV vaccinations since 2012 when determining that it was necessary to conduct an HPV vaccination pilot before deciding on a national roll-out; and if he will make a statement.
tabling member constituency	Hazel Grove
tabling member printed	William Wragg
uin	38847
answer	answer is ministerial correction date of answer 10/06/2016 answer text <p>Experience from the two Brent and Harrow clinics providing human papillomavirus vaccinations to men who have sex with men was shared with Public Health England and has helped to inform the development of the pilot. North West London is unlikely to be representative of England as a whole and the pilot will therefore let us consider provision of this vaccination programme in different geographical areas. It will also consider a wider age range than the service provided in these two clinics. The pilot will cover men up to 45 years of age in line with advice from the Joint Committee on Vaccination and Immunisation (JCVI). The pilot will help resolve a range of implementation issues and determine whether a national programme can be delivered through Genito-Urinary Medicine and HIV clinics at a cost effective price in line with the JCVI’s advice.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/06/2016 10:59:07 answering member 3918 label Biography information for Jane Ellison
tabling member	4429 label Biography information for Mr William Wragg